Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06379893 · ClinicalTrials.gov registry record · Phase 4
A Real-World Evidence Study to Evaluate the Effects of Voltaren Use on Mobility and Quality of Life in Participants With Knee Osteoarthritis Pain
A Phase 4 study, sponsored by HALEON.
- Completed
- Registry status
- Phase 4
- Development phase
- 196
- Enrollment target
NCT06379893 is a Phase 4 study that has completed, run by HALEON. The registered enrollment target is 196 participants.
The verdict
NCT06379893, a Phase 4 study, has completed, sponsored by HALEON.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 196 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate how topical diclofenac use can improve functional mobility and physical activity primarily, as well as other quality-of-life (QoL) parameters such as sleep, mood, and engagement in daily activities in participants with knee OA.
Interventions
- DRUG Voltaren Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2024-04-25 |
| Est. Completion | 2024-10-29 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06379893
The ClinicalTrials.gov registry entry for NCT06379893 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 196 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HALEON, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Voltaren Gel is the first listed.
NCT06379893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06379893 about?
NCT06379893 is a clinical study titled "A Real-World Evidence Study to Evaluate the Effects of Voltaren Use on Mobility and Quality of Life in Participants With Knee Osteoarthritis Pain". The purpose of this study is to investigate how topical diclofenac use can improve functional mobility and physical activity primarily, as well as other quality-of-life (QoL) parameters such as sleep, mood, and engagement in daily activities in participants with knee OA.
What is the current status of trial NCT06379893?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 196 participants. The study started on 2024-04-25. Estimated completion is 2024-10-29.
What interventions are being tested in trial NCT06379893?
The interventions under investigation include: Voltaren Gel (DRUG).
Who is sponsoring clinical trial NCT06379893?
This trial is sponsored by HALEON, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.